search
Back to results

Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft

Primary Purpose

Pain, Post Operative, Quality of Life

Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Ibuprofen 600 mg
Placebo
Acetaminophen
Sponsored by
Marquette University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pain, Post Operative

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria Age >18 years Good general health (controlled conditions) Fluent in English Treatment-planned for single site extraction and bone graft surgery Exclusion criteria Pregnancy Site with active infection i.e purulence, abscess formation Patients experiencing pain pre-operatively Oral surgery in more than one site/quadrant in the same session Patients receiving surgery under sedation Patients with any contraindication for oral bone grafting surgery (e.g., on anticoagulants, medication-related osteonecrosis of the jaw, etc.) Patients experiencing acute or chronic oral pain due to conditions or previous interventions Patients with diseases or taking medications that affect hard and soft tissue wound healing such as poorly controlled diabetes, bisphosphonate use, corticosteroid use, chemotherapy, immunosuppressive therapy, etc. Current or chronic (≥4 weeks) use of anti-inflammatory, analgesic, corticosteroid or sedative medications in the past 6 months Health conditions that contraindicate the use of NSAIDs, such as stomach ulcers, bleeding disorders, renal disfunction, liver cirrhosis or acute liver disease, etc. Intake of medications that interact with NSAIDs or whose actions can be affected by NSAIDs, such as anticoagulant/antiplatelet medications, ACE inhibitors, diuretics, etc. Allergy to ibuprofen, acetaminophen and/or aspirin, and study materials (e.g., sutures, grafts, membranes?). Patients having 3 or more alcoholic beverages daily Patients who are planned to undergo heart surgery or had heart surgery less than 6 months prior Not fluent in English

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Ibuprofen group or Test Group

    Placebo group or Control group

    Arm Description

    Subjects will be given ibuprofen 600mg tab 1h prior to surgery.

    Subjects will be given a placebo tab 1h prior to surgery.

    Outcomes

    Primary Outcome Measures

    Difference in patient-reported postoperative pain between test and control group
    Visual Analogue Scale will be used to measure patient-reported pain. Its score range from 0-100 and the higher the score, the worse the reported pain is. Specifically, zero represents no pain and 100 represents the worst pain imaginable.

    Secondary Outcome Measures

    Difference in patient-reported postoperative pain between test and control group
    Visual Analogue Scale will be used to measure patient-reported pain. Its score range from 0-100 and the higher the score, the worse the reported pain is. Specifically, zero represents no pain and 100 represents the worst pain imaginable.
    Difference in Oral Health Impact Profile-14 between test and control group
    Oral Health Impact Profile-14 is a validated widely used questionnaire that reliably measures oral health-related quality of life by recording patient perception of the impact of oral conditions on their well-being. Specifically, it consists of seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. Its scores range from 0-56 and the higher the total score, the more impacted, i.e., worse, the quality of life is.

    Full Information

    First Posted
    June 9, 2023
    Last Updated
    October 17, 2023
    Sponsor
    Marquette University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05919745
    Brief Title
    Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft
    Official Title
    Patient Perception of Pain Following Extraction and Bone Graft Surgery With or Without Preemptive Ibuprofen: A Randomized Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 2023 (Anticipated)
    Primary Completion Date
    December 2026 (Anticipated)
    Study Completion Date
    December 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Marquette University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The goal of this randomized clinical trial is to compare patient-reported pain and oral health-related quality of life during the first postoperative week following extraction and bone graft surgery in patients who received preemptive ibuprofen versus placebo. Participants will receive ibuprofen 600mg or placebo by mouth with water 1 hour prior to extraction and bone graft surgery. The primary question it aims to answer is: • Does preemptive ibuprofen have an effect on postoperative pain 1 hour following extraction and bone graft surgery compared to placebo? Secondary questions are: Does preemptive ibuprofen have an effect on pain during the first 3 postoperative hours and 7 postoperative days following extraction and bone graft surgery compared to placebo? Does preemptive ibuprofen have an effect on oral health-related quality of life during the 7 postoperative days following extraction and bone graft surgery compared to placebo?
    Detailed Description
    The null hypothesis of this randomized clinical trial is that there is no difference in patient-reported pain and oral health-related quality of life during the first postoperative week following extraction and bone graft surgery between patients who received 600mg of preemptive ibuprofen versus placebo. Participants will receive ibuprofen 600mg (test group) or placebo (control group) per os 1 hour prior to extraction and bone graft surgery. Researchers and patients will be blinded to the group assignment. Both groups will be given rescue medication in the form of 1,000 mg tabs of acetaminophen every 6 hours as needed for pain (maximum allowed daily dose 4,000 mg per FDA) and will be allowed to receive ibuprofen or other analgesic medication as needed if pain is not controlled by acetaminophen alone. The subjects will receive the rescue medication pills at the end of the surgical appointment. Patient-reported pain will be collected by Visual Analogue Scale (VAS) before surgery, every hour for the first 3 postoperative hours and on postoperative days 1-7. VAS for patient-reported swelling will also be recorded at the same time points. Number of rescue medications will be recorded at the same postoperative time points. Oral health-related quality of life as expressed by Oral Health Impact Profile-14 (OHIP-14) questionnaire will be reported before surgery and on postoperative days 2, 5 and 7. Questionnaires on dental anxiety (Modified Dental Anxiety Scale), oral health literacy (Rapid estimate of Adult Literacy in Dentistry 30 Short Form), fear of pain (Fear of pain questionnaire-9) and pain catastrophizing (Pain catastrophizing scale) will be collected prior to surgery and will be evaluated as pain modifiers. Anticipated pain will be reported prior to surgery and questions on comparison between actual and anticipated pain and willingness to undergo a similar procedure again will be asked on days 1 and 7. Surgical and demographic data as well as medical history will be collected on the day of surgery. Clinical wound healing observations will be recorded on day 7.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Post Operative, Quality of Life

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    50 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Ibuprofen group or Test Group
    Arm Type
    Experimental
    Arm Description
    Subjects will be given ibuprofen 600mg tab 1h prior to surgery.
    Arm Title
    Placebo group or Control group
    Arm Type
    Placebo Comparator
    Arm Description
    Subjects will be given a placebo tab 1h prior to surgery.
    Intervention Type
    Drug
    Intervention Name(s)
    Ibuprofen 600 mg
    Other Intervention Name(s)
    Test
    Intervention Description
    Preoperative delivery of ibuprofen per os.
    Intervention Type
    Drug
    Intervention Name(s)
    Placebo
    Other Intervention Name(s)
    Control
    Intervention Description
    Preoperative delivery of placebo per os.
    Intervention Type
    Drug
    Intervention Name(s)
    Acetaminophen
    Other Intervention Name(s)
    Rescue medication
    Intervention Description
    Both groups will be given rescue medication in the form of 1,000 mg tabs of acetaminophen every 6 hours per os as needed for pain (maximum allowed daily dose 4,000 mg per FDA) and will be allowed to receive ibuprofen or other analgesic medication as needed if pain is not controlled by acetaminophen alone. The subjects will receive the rescue medication pills at the end of the surgical appointment.
    Primary Outcome Measure Information:
    Title
    Difference in patient-reported postoperative pain between test and control group
    Description
    Visual Analogue Scale will be used to measure patient-reported pain. Its score range from 0-100 and the higher the score, the worse the reported pain is. Specifically, zero represents no pain and 100 represents the worst pain imaginable.
    Time Frame
    1 hour following extraction and bone graft surgery
    Secondary Outcome Measure Information:
    Title
    Difference in patient-reported postoperative pain between test and control group
    Description
    Visual Analogue Scale will be used to measure patient-reported pain. Its score range from 0-100 and the higher the score, the worse the reported pain is. Specifically, zero represents no pain and 100 represents the worst pain imaginable.
    Time Frame
    Postoperative hours 2 and 3, and postoperative days 1, 2, 3, 4, 5, 6 and 7 following extraction and bone graft surgery.
    Title
    Difference in Oral Health Impact Profile-14 between test and control group
    Description
    Oral Health Impact Profile-14 is a validated widely used questionnaire that reliably measures oral health-related quality of life by recording patient perception of the impact of oral conditions on their well-being. Specifically, it consists of seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. Its scores range from 0-56 and the higher the total score, the more impacted, i.e., worse, the quality of life is.
    Time Frame
    Postoperative days 2, 5 and 7 following extraction and bone graft surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria Age >18 years Good general health (controlled conditions) Fluent in English Treatment-planned for single site extraction and bone graft surgery Exclusion criteria Pregnancy Site with active infection i.e purulence, abscess formation Patients experiencing pain pre-operatively Oral surgery in more than one site/quadrant in the same session Patients receiving surgery under sedation Patients with any contraindication for oral bone grafting surgery (e.g., on anticoagulants, medication-related osteonecrosis of the jaw, etc.) Patients experiencing acute or chronic oral pain due to conditions or previous interventions Patients with diseases or taking medications that affect hard and soft tissue wound healing such as poorly controlled diabetes, bisphosphonate use, corticosteroid use, chemotherapy, immunosuppressive therapy, etc. Current or chronic (≥4 weeks) use of anti-inflammatory, analgesic, corticosteroid or sedative medications in the past 6 months Health conditions that contraindicate the use of NSAIDs, such as stomach ulcers, bleeding disorders, renal disfunction, liver cirrhosis or acute liver disease, etc. Intake of medications that interact with NSAIDs or whose actions can be affected by NSAIDs, such as anticoagulant/antiplatelet medications, ACE inhibitors, diuretics, etc. Allergy to ibuprofen, acetaminophen and/or aspirin, and study materials (e.g., sutures, grafts, membranes?). Patients having 3 or more alcoholic beverages daily Patients who are planned to undergo heart surgery or had heart surgery less than 6 months prior Not fluent in English
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Vrisiis Kofina, DDS, MS
    Phone
    516-817-0393
    Email
    vrisiis.kofina@marquette.edu
    First Name & Middle Initial & Last Name or Official Title & Degree
    Christos Gousias, DDS
    Phone
    414-229-8875
    Email
    christos.gousias@marquette.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Vrisiis Kofina, DDS, MS
    Organizational Affiliation
    Marquette University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Preemptive Ibuprofen Effects on Pain Perception Following Extraction and Bone Graft

    We'll reach out to this number within 24 hrs